A class action lawsuit has been filed against Inspire Medical Systems Inc. on behalf of investors who suffered losses between August 6, 2024, and August 4, 2025, due to alleged securities fraud. The complaint alleges that Inspire Medical Systems made false statements and concealed problems surrounding the launch of its new product, Inspire V. Despite assurances of a successful rollout, the company reportedly faced poor demand for the product, with providers holding surplus inventory and showing reluctance to adopt the new treatment. The lawsuit further claims that the company failed to complete essential launch tasks, including training and onboarding treatment centers, setting up basic IT systems, updating critical insurer claims software, and ensuring Medicare reimbursement processes were in place. These issues allegedly led to significant challenges and misled investors regarding the company's actual performance and prospects.